Category: Research

Australian researchers, coordinating with teams from Germany, have trialled genetically-modified algae loaded with chemotherapy drugs and found that they destroy 90% of cancer cells while leaving healthy ones intact.

Claiming to be a world’s first, Canadian scientists have used targeted ultrasound and microbubbles to deliver chemotherapy drugs directly into brain tumours.

The American Brain Tumour Association (ABTA), founded in 1973 and based in Chicago, has announced it is awarding $1million in new research grants.

Scientists have discovered a protein that is produced inside the blood vessels at the invasive edge of brain tumours.

Physicists from the University of Sydney are using synthetic nano-diamonds (molecular levels of size) to identify cancer cells during non-invasive MRI scans.

New imaging technology may allow neurosurgeons to distinguish between tumour tissue and normal brain tissue in real time

Developing a new drug is hugely expensive. The whole process – from initial laboratory tests through clinical trials to licensing for use in humans (if it gets that far) – is time-consuming and often frustrating.

An enhanced Australian rabbit virus may pave the way for future drug-virus treatments of GBM.

The American Food and Drug Administration (FDA) has just approved Optune for the treatment of gioblastoma multiforme (GBM) patients.

A pioneering development in Gamma Knife radiosurgery treatment of brain tumours is undergoing trials at Bristol Royal Infirmary.

We are delighted to announce an overwhelmingly positive response to our latest appeal for research ideas, with a host of teams bidding to drive forward progress towards defeating brain tumours.

People with a brain tumour could be prevented from accessing low cost and readily available drugs that have been proven to treat their tumour because the drugs are no longer covered by a manufacturer’s patent. Ask your local MP to vote in favour of the Off-Patent Drugs Bill on 6th November to ensure we change this.

Research published online today in the scientific journal Neuro-oncology has shown that some of the questionnaires completed by patients, parents and teachers relating to the behaviour, emotional wellbeing and quality of life of children affected by a brain tumour can flag reductions in IQ.

We welcome the publication of the ‘Top 10 Neuro-Oncology Uncertainties’, identified by the James Lind Alliance (JLA) as having highest importance to people with a brain tumour.

To mark International Clinical Trials Day on 20 May, we are supporting the Ok to Ask campaign, getting more patients enrolled in clinical trials.

Funded by The Brain Tumour Charity, Dr Chris Jones at the Institute of Cancer Research has deepened our understanding of childhood high grade gliomas.